Moleculera Labs, Inc. — Form D
Moleculera Labs, Inc. of Oklahoma City, OK, a company, filed a Form D exempt-offering notice with the SEC on 2013-10-18. The offering totals $3.2M, of which $3.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2013-10-18
- Form: D
- Accession: 0001209191-13-048726
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $3.2M
- Amount sold: $3.0M
- Remaining: $250K
- Minimum investment: $10K
- Investors: 28
- Date of first sale: 2013-09-20
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-204863
Issuer
- Name: Moleculera Labs, Inc.
- CIK: 0001537411
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2012
- Address: 800 Research Parkway, Suite 384, Oklahoma City, OK, 73104
- Phone: 405-239-5250
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Craig Shimasaki, PhD, MBA | Director | Oklahoma City, OK |
| David Thomison | Director | Oklahoma City, OK |
| Fred Hiller | Executive Officer | Oklahoma City, OK |
| Craig Shimasaki, PhD, MBA | Executive Officer | Oklahoma City, OK |
| Dr. Madeleine Cunningham | Executive Officer | Oklahoma City, OK |
| Madeleine Cunningham | Executive Officer | Oklahoma City, OK |
Other filings by this issuer (2)
More